olmesartan has been researched along with imidapril in 2 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (imidapril) | Trials (imidapril) | Recent Studies (post-2010) (imidapril) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 238 | 62 | 38 |
| Protein | Taxonomy | olmesartan (IC50) | imidapril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 9.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamide, K; Maekawa, Y; Ohishi, M; Onishi, M; Rakugi, H; Takeya, Y; Tatara, Y; Yamamoto, K | 1 |
| Fujita, E; Higo, S; Hirama, A; Iino, Y; Kaneko, T; Katayama, Y; Mii, A; Mishina, M; Ueda, K; Utsumi, K; Watanabe, Y; Yasuda, F | 1 |
1 trial(s) available for olmesartan and imidapril
| Article | Year |
|---|---|
Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: high-dose ARB with ACE inhibitor (Hawaii) study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Female; Hawaii; Humans; Hypertension; Imidazoles; Imidazolidines; Kidney; Kidney Diseases; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2010 |
1 other study(ies) available for olmesartan and imidapril
| Article | Year |
|---|---|
Effects of olmesartan and imidapril on the plasma adiponectin, P-selectin, and MDA-LDL levels of diabetic nephropathy patients.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Female; Humans; Imidazoles; Imidazolidines; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; P-Selectin; Tetrazoles | 2012 |